Alan Moses, MD, FACP
Former CMO of Novo Nordisk, including GLP-1 development. Former Professor of Medicine at Harvard Medical School and Former CMO at Joslin Diabetes Center.
Michael Zemel, PhD
Former Professor of Medicine, Nutrition and Metabolism University of Tennessee. Dr. Zemel leads research programs focused on energy-sensing and development of therapeutics for…
Alexander Fleming, MD
Former Senior Medical Officer, Division of Metabolic and Endocrine Drug Products, FDA
